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Meeting the Workforce Needs of New Jersey’s
Pharmaceutical and Medical Technology Industries
This analysis presents the results of a workforce supply and demand analysis performed by the John J. Heldrich
Center for Workforce Development, undertaken at the request of the HealthCare Institute of New Jersey (HINJ) and
a number of its member companies.  Since 1998, the Heldrich Center and HINJ have partnered to address the
emerging and long-term workforce needs of New Jersey’s pharmaceutical and medical technology industry.  This
industry currently employs more than 66,000 individuals in the state and represents one of the pillars of New
Jersey’s economy.  The partners believe the private sector, government, and educational institutions in New Jersey
can work together on a common, sector-wide approach to develop and enact a far-reaching workforce develop-
ment strategy.  To accomplish this goal, business and policy leaders must have a detailed understanding of the
needs of the industry (demand), and the qualifications and availability of existing and potential workers (supply)
over the next several years.   This data is being presented to government and primary, secondary, and higher edu-
cation leaders to strengthen existing partnerships and build future dialogue.
LOOKING AHEAD: A Workforce Supply and Demand Analysis for New Jersey’s Pharmaceutical and Medical Technology Industries
A Demand Analysis of
the State of the
Pharmaceutical and
Medical Technology
Workforce and its
Future Needs
HealthCare Institute of New Jersey (HINJ)
companies employ approximately 66,000
individuals and expect to continue expand-
ing their workforce this decade, according to
2000 figures. 1 The total workforce of the
companies studied in this
analysis is 48,496.2
According to the U.S.
Census Bureau, by 2008,
New Jersey businesses
will need to fill nearly
half a million new jobs.
Approximately 200,000
of these will require an
associate’s degree or
more, another 64,000
will require at least some
post-secondary education,
and 200,000 will only require basic skills and
on the job training.3
Many of these higher-skilled jobs are in New
Jersey’s growing pharmaceutical and medical
device sector.  Nearly three-fourths (73%, or
35,318) of pharmaceutical/MT jobs are busi-
ness related, and a majority of the industry’s
current jobs (62%, or 30,048) require at
least a bachelor’s degree.4 Nearly one-
fourth (24%, or 11,839) of current jobs are
extremely highly skilled, requiring a mas-
ter’s, Ph.D., or M.D.  Over the next year, com-
panies anticipate that more than two-thirds
(67%, or 3,794) of the jobs they create will
require at least a bachelor’s degree, while
more than one-fourth (27%, or 1,142) will
require an advanced degree beyond a bache-
lor’s (see Fig.1).
In examining the educational back-
ground of the sector’s current workforce,
Figure 1
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this analysis finds that nearly one-fifth (19%,
or 9,214) of current employees have a bach-
elor’s degree in science or math, 8% (or
4,031) have a Ph.D./MD in science or math,
18% (or 8,753) have a degree in business,
and 5% (or 2,391) have a degree in technolo-
gy. Approximately one-third (34%, or 16,259)
of the sector’s workforce has less than an 
associate’s degree.  
In examining hiring needs and trends
among companies participating in our study
over the next five years, our analysis arrived
at a number of clear conclusions.
Companies expect high job growth in basic
1 HealthCare Institute of New Jersey 2000 Annual Survey of Institute Members. Prepared by PricewaterhouseCoopers LLP, March 2000.
2 Based on data submitted by participating companies between January 2001 and June 2002.
3 Workforce Partnership: Draft Report October 26, 2001. State of New Jersey, Prosperity New Jersey. October 2001.
4 All industry statistics in this report are specific to New Jersey, and do not include company divisions located outside the state.
Science and
math degrees are 
projected to be in
the greatest
demand, command-
ing 46% (or 1,205) 
of projected total 
job growth in 2002
and 44% (or 2,510)
in 2007.
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research, operations, and corporate adminis-
tration—many of which will require bache-
lor’s degrees. Science and math degrees are
projected to be in the greatest demand,
commanding 46% (or 1,205) of projected
total job growth in 2002 and 44% (or 2,510)
in 2007. The demand for
business degrees will
also increase over the
next several years, pro-
jected to comprise 18%
(or 472) of total job
growth in 2002, and
36% (or 2,053) in 2007.
The demand for technol-
ogy degrees is projected
to remain steady, with a
projected increase of only
7% in 2002 and 7% in 2007, respectively (or
183 and 399, respectively).  The demand for
engineering degrees to meet net job growth,
after an upward spike in 2002, is expected
to decrease significantly in 2007 (29% and
12%, respectively, or 760 and 685, respec-
tively).  As with current vacancies, the posi-
tions requiring advanced degrees in math,
science, technology, and business are
deemed “difficult to fill” by participating
companies.  Jobs requiring advanced science
and technical degrees are going to be the
vast majority (70%) of all jobs requiring
advanced degrees (see Fig.2 and Fig.3). 
Figure 2
Projected New Hires by Degree Show That Two-Thirds of Workforce
Will Require At Least a Bachelor’s Degree by 2007
DEGREE PROJECTED % OF PROJECTED % OF
REQUIREMENT HIRES 2002 2002 HIRES HIRES 2007 2007 HIRES
High School Diploma 820 31% 1837 32%
Associate’s Degree 55 2% 74 1%
Bachelor’s Degree 1039 40% 2652 46%
JD 30 1% 131 2%
MBA 65 2% 253 4%
Master’s (other than 
business) 287 11% 417 7%
Ph.D. 282 11% 268 5%
MD/DVM 42 2% 73 1%
Jobs requiring
advanced science
and technical
degrees are going to
be the vast majority
(70%) of all jobs
requiring advanced
degrees (see Fig.2
and Fig.3). 
Figure 3
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In short, a major workforce challenge
facing the pharmaceutical and medical tech-
nology industries is filling jobs that require
high levels of education, particularly those
requiring master’s (excluding MBAs), and
Ph.D. degrees in science and related fields.
The absolute number of these difficult to fill
positions-such as the 48% of technical jobs-
is projected to grow from 499 today to 758
by 2007.  Senior Human Resource officials
in the pharmaceutical and medical technol-
ogy industries express concern that the
scarcity of these workers will continue and
even intensify unless something is done
now to address the problem.
A Supply Analysis of
New Jersey’s Emerging
Workforce
According to the New Jersey Department of
Labor, from 1990 to 1998, the New Jersey
civilian workforce grew by less than 2%,
despite being a time of strong job growth
and economic expansion.  If this trend con-
tinues, there will be an insufficient supply
of graduates in fields demanded by the
pharmaceutical and medical technology
industry or to other high technology and
health related fields.  
On the whole, the New Jersey popula-
tion is becoming better educated and more
individuals are graduating from New Jersey
higher education institutions with degrees
Figure 4
Projected Net Growth by Category Shows Nearly Half of 
New Jobs By 2007 Will Be R&D Related
% Current % of Net % of Net 
Major Job Category Workforce Growth 2002 Growth 2007
Corporate Admin 31% 18% 26%
Sales 8% 2% 9%
Marketing 7% 4% 11%
Basic Research 12% 28% 15%
Clinical Development 15% 16% 14%
Technical operations 21% 25% 19%
Quality Management 5% 6% 6%
Total 100% 100% 100%
Figure 5
Workforce Supply and Demand Analysis by Degree
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1. Biomedical Engineering MS 1. Biological Science PhD
2. Chemical Engineering MS 2. Genetics/molecular biology/cell biology MS
Low Supply - Low Demand Low Supply - High Demand 
1. Genetics/molecular biology/cell biology PHD 1. Chemistry PhD
2. Genomics PhD 2. Biochemistry PhD
3. Medicine PhD 3. Chemical Engineering PhD
4. Microbiology PhD 4. Pharmaceutical Science PhD
5. Toxicology PhD 5. Chemical Engineering PhD
6. Biochemistry MS 6. Chemistry MS
7. Genomics MS 7. Physical Science MS
8. Medicine MS 8. Biological Science MS
9. Integrative Neuroscience MS
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Figure 6
What Tomorrow’s Workers Had to Say: Nearly One-Half of High
School Students Have Not Taken or Plan to Take Math and Science
Advanced Placement Courses
Figure 7
Most Students Say They Are Willing to Train or Study in 
Specific Areas for Better Jobs
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appropriate to work in
the pharmaceutical and
medical technology sec-
tor.  However, in compar-
ing the projected degrees
demanded by the indus-
try with the graduation
trends of those degrees,
it is clear that there are
not sufficient numbers of
individuals with
advanced math and sci-
ence degrees graduating
from New Jersey higher
education institutions.  If
current trends continue,
New Jersey higher educa-
tion institutions will not
produce enough individu-
als with Ph.D.s and MS science degrees to
meet industry demand.
The “Pipeline:” New
Jersey High School
Juniors and Seniors
Over the next several years, the pharmaceu-
tical and medical technology industries will
continue to experience a shortage of avail-
able workers with advanced degrees in sci-
ence. To meet this demand, there must be an
increase in the supply of qualified gradu-
ates.  The choices students make in their
pre-college education can preclude them
from being competitive in math/science 
However, in
comparing the pro-
jected degrees
demanded by the
industry with the
graduation trends
of those degrees, it
is clear that there
are not sufficient
numbers of individ-
uals with advanced
math and science
degrees graduating
from New Jersey
higher education
institutions.
Figure 8
Students Support Incentives to Join Industry After Graduation
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college level programs, often resulting in
under-enrollment in industry-related course
offerings.  Therefore, the eventual supply of
qualified workers available to the industry is
contingent upon the decisions and actions
of high school students.  
A survey of 500 New Jersey high school
juniors and seniors reveals some disturbing
trends for the pharmaceutical/MT indus-
tries-and some distinct possibilities for posi-
tive change.  Nearly half (46%) of all high
school juniors and seniors have taken no
math or science honors/AP courses, and
48% do not anticipate taking either before
completing high school (see Fig.6). More
than half (56%) of New Jersey high school
students say they are not very
or not at all familiar with
the types of jobs available
in the pharmaceutical and
medical technology
industries (36% and
20%, respectively). 
More than half (60%)
of those surveyed who
currently do not plan on
majoring in either busi-
ness, science or technolo-
gy say they would be will-
ing to major in one of
these subject areas if they
believed it would result in
better job opportunities after graduation.
The vast majority (84%) say that they would
consider enrolling in a college program that
is designed to train them for a specific job in
a specific industry if they believed it would
result in better job opportunities after grad-
uation (see Fig.7).   
More than half (58%) of students say
they would be interested in a summer
internship at a pharmaceutical or medical
technology company during their education,
and nearly three-fourths (73%) say they
would commit to working at a pharmaceuti-
cal or medical technology company for a few
More than
half (56%) of New
Jersey high school
students say they
are not very or not
at all familiar with
the types of jobs
available in the
pharmaceutical 
and medical
devices industries
(36% and 20%, 
respectively). 
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years after completing college or technical
school if the company helped pay for their
tuition (see Fig.8).
Methodology
Research methods included a quantitative
workforce demand analysis using data and
projections from seven companies repre-
senting 80% of the HINJ members’ total
pharmaceutical and medical technology
workforce; structured interviews with senior
human resource executives in the pharma-
ceutical and medical technology sector; a
quantitative workforce supply analysis using
college and university graduation data by
degree and area of specialization structured
interviews with senior academic officers of
New Jersey higher education institutions; a
telephone survey of 500 New Jersey high
school juniors and seniors assessing their
awareness of and interest in the pharmaceu-
tical and medical technology industries; and
an analysis of promising strategies currently
underway in several states and communities
around the country.  This initiative was fund-
ed by the following participating companies:
Wyeth, Aventis Pharmaceuticals, Bristol-
Myers Squibb, Hoffmann-La Roche Inc.,
Johnson & Johnson, Merck & Co., Inc.,
Novartis, Organon Inc., Schering-Plough
Corporation, and Stryker Howmedica
Osteonics.   
 Amersham Health works closely with
Inroads of New Jersey, a group that
works with minority college students.
Private sector companies sponsor these
students throughout their college educa-
tion. The goal of the program is to place
students with their sponsor company
after graduation.
 Amersham Health is working to form a
partnership with the Rutgers University
Pharmacy Program, focusing on building
awareness among students of future
careers in nuclear pharmacy. Amersham
plans to be a part of Rutgers’ next career
fair in October/November 2002.
 Amersham Health also works closely with
the New Jersey Institute of Technology.
The company’s Information Management
Group sponsors students to work with the
department with the hope of hiring these
students upon graduation.
 Amersham Health hosts an annual "Take
Your Child To Work Day," during which
the company provides children with infor-
mation about the medical side of
Amersham Health, as well as all aspects
of the workforce. 
AVENTIS PHARMACEUTICALS
Bridgewater
Aventis Pharmaceuticals was created by the
December 1999 merger of Hoechst Marion
Roussel and Rhône-Poulenc Rorer. Aventis
Pharmaceuticals has one of the industry’s
largest R&D budgets, largest sales forces and a
robust pipeline. The company has significant
presence and important prescription products
in all major pharmaceutical markets, from
Europe to North America, Asia to Latin
America. In addition, Aventis Pharmaceuticals
possesses a broad scope of enabling technolo-
gies, such as functional genomics, combinatori-
al chemistry, high-throughput screening and
immunology. 
In Somerset County, the existing Bridgewater
campus is headquarters for the company’s
Global Drug Development Center and U.S. Drug
Innovation and Approval organizations. In
1998, a $45 million facility was completed
that doubled this site’s research capacity; dur-
ing the next several years, the site is expected
to double in overall capacity. 
Aventis Pharmaceuticals has been recognized
for its contributions to the community and
the state, including philanthropic activities in
education, health and human services as well
as its employee volunteers. The company has
been recognized with a “Good Neighbor”
Award from the State and an “Economic
Vitality” Award from the Somerset County
Chamber of Commerce.     
 Aventis offers a $1 to $1 match through 
its Matching Gift Program to 501(c)(3) 
educational organizations. These organi-
zations must be accredited colleges and 
universities or primary/secondary public 
and private schools that meet qualifying 
criteria and are open to all students. 
AMERSHAM HEALTH
Princeton 
Amersham Health, a business of Amersham
plc, is the leading global pharmaceutical
provider of diagnostic and predictive imaging
products and services. Amersham Health is
dedicated to providing healthcare professionals
with products that expand and improve their
diagnostic capabilities and contribute to the
treatment of disease. Amersham Health is
committed to finding innovative diagnostic
and therapeutic solutions with a focus on car-
diology, neurology and cancer. 
Amersham plc is a world leader in medical
diagnostics and in life sciences. Headquartered
in the UK, the company's strategy is to build
its position as a leading provider of products
and technologies enabling disease to be better
understood, diagnosed earlier and treated
more effectively.
Amersham Health is involved with several
educational initiatives in New Jersey, 
including:
WORKFORCE PARTNERSHIPS OF NEW JERSEY’S PHARMACEUTICAL AND MEDICAL TECHNOLOGY INDUSTRY
The following section is a compilation of
the workforce and training partnerships
currently undertaken by the member com-
panies of the HealthCare Institute of New
Jersey (HINJ).  It is not part of the John J.
Heldrich Center for Workforce
Development’s research for HINJ, but is pro-
vided by each company to the public and
the press for informational purposes.
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In 2001, we matched over $175,000 
to educational organizations on a 
national basis.
 In 2001, Aventis employed 56 college 
interns.  In 2002, 96 students participat-
ed in the summer internship program.  
Over half of these students are from New 
Jersey colleges and universities, with the
majority attending Rutgers.  In addition, 
there were eight students from Inroads of
New Jersey, a group that works with 
minority college students.  
Aventis Science Outreach Program
Through the Science Outreach Committee,
Aventis promotes science to students at local
schools. A group of Aventis scientists provide
outreach to students in grades K-12 to show
them that science can be fun and applicable
to the real world, and that there are many
diverse and rewarding careers in the sciences.
By developing potential scientists, Aventis
helps future generations set and achieve high
performance standards.
Activities of the Science Outreach Committee
include:
 Scholarships to graduating high school 
students.
 In-classroom demonstrations and lectures
 Guided tours of Aventis laboratories.
 WebCT funding.
 Science fair judging.
For the past 10 years, Aventis awards gradu-
ating seniors from local high schools with
special achievement awards. This year, 14
$1,000 Aventis Achievement Awards in
Chemistry and three $1,000 Aventis Achieve-
ment Awards in Biology will be presented at
each school.
Aventis also participates in the “Bridge to
Employment” program at Bridgewater-Raritan
Regional High School, which helps students
develop a clear understanding of a successful
career in the pharmaceutical industry.
Students, working with scientists from
Aventis, participate in selected activities that
provide knowledge of the range of career
opportunities available and the required train-
ing and skills needed to succeed in a science-
related career. 
To further the students’ interest, Aventis sci-
entists conduct science demonstrations in the
school. They also serve as mentors and dis-
cuss various careers in the pharmaceutical
industry, but specifically about their own
expertise. The scientists also conduct tours of
the labs at the Aventis research facilities in
Bridgewater. During these tours, students can
see the typical work done at Aventis and get
a sense of what it is like to work in research
at a pharmaceutical company. 
Aventis also has funded the licensing of an
Internet course-authoring program “WebCT.”
This program allows teachers to easily create
on-line course material and also allows for
extended communication through focused
chat rooms and secures e-mail. Students have
used this program to refer back to assign-
ments, prepare for exams and ask questions
outside of class. In order to provide easy
access to the Internet, Aventis has also pro-
vided multimedia and computer equipment.
 Aventis will be participating in the 
2002/2003 Bridgewater-Raritan Regional 
High School International Business 
Practice Forum, an elective course where 
students in grades 9–12 are corporate 
employees of their own business. Aventis
will provide funding and 20 computers, 
in addition to volunteers who will act 
as mentors, to the students for the 
school year.
 Beginning with the 2001/2002 school 
year, Aventis committed to $6,000 per 
year for eight years to support St. 
Michael’s School in Newark with their 
Adopt-A-Kid program. Aventis’ sponsor-
ship will provide scholarships for six 
kids per year.
 Aventis has committed to $100,000 
over three years, beginning in 2001, for 
Raritan Valley Community College to sup-
port the Galileo Project for scholarships 
and program development in the science, 
math and nursing fields.
BD
Franklin Lakes
BD manufactures and sells a wide range of
medical supplies, devices and diagnostic sys-
tems used by health care professionals, med-
ical research institutions, and patients around
the world. Our company is dedicated to a sin-
gle proposition: to become the organization
most known for eliminating unnecessary suffer-
ing and death from disease and, in so doing,
become one of the best managed companies in
the world. 
BD is currently engaged in a number of work-
force partnerships in New Jersey and assis-
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tance programs with elementary and high
school districts in the state.                         
 Through the BD Matching Gift Program, 
the 501(c)3 company supports employee 
donations to local educational founda-
tions that are 501(c)3 organizations and 
private schools (K-12) in the state. For 
2001-2002, BD matched $17,400 to K-12 
organizations, and in 2000 the company  
matched up to $31,000.
 Sponsors a program with Fairleigh 
Dickinson University and the Henry P. 
Becton School of Nursing in which stu-
dents have a clinical rotation at BD. 
Students come in for a one-day observa-
tion experience day.  The rotation serves 
25 students throughout the semester.
 As part of the Ramapo College Nursing 
program, BD staff lecture on occupational
health nursing and industrial hygiene.  In
addition, students are invited to tour BD,
and Ramapo students doing senior proj-
ects come to work at BD for a semester.
 BD hired 47 summer interns in 2002, 
almost half of which come from New 
Jersey schools (Rutgers University and 
Stevens Institute of Technology).
In addition, BD has made numerous financial
contributions, including:
 UMDNJ–School of Health Related 
Professions.
 Established the BD Multimedia Health 
Care Teaching Center  at the Newark 
Campus of the University of Medicine and
Dentistry of New Jersey to support a 
training site for health care professionals.
It serves central and remote locations 
through distance learning technologies 
and laboratories and a resource for 
product development through consulta-
tion with clinical faculty, simulation of 
clinical experiences and collaborative 
problem solving.   This is a five-year 
pledge (FY98 to FY02) for $1 million.
 Independent College Fund of New Jersey/
Fairleigh Dickinson University, to estab-
lish the Henry P. Becton School of 
Nursing and Allied Health at FDU. Funds 
provided to support renovation of 
Dickinson Hall, which houses the nursing 
school and its laboratories. The school 
has a four-year baccalaureate degree 
program, a master’s program and a one-
year accelerate bachelor’s degree program
in nursing. This was a seven-year pledge 
(FY95 to FY01) for $1 million.
 Hosts yearly Take your Children to Work 
events.  
BERLEX LABORATORIES
Montville 
Berlex, a biopharmaceutical company and the
U.S affiliate of Schering AG, Germany, is the
maker of diagnostics and specialty medicines
for women’s health, multiple sclerosis, cancer,
heart disease and dermatology.  Headquartered
in New Jersey, Berlex also maintains operations
in northern California, Puget Sound and New
Hapmshire.
Its active cadre of employee volunteers was
among the reasons Berlex was named New
Jersey Corporate Philanthropist of the Year in
2002.  Many of its community relations pro-
grams center on enriching education and
helping young people in need in the region.
 Berlex Science Scholarships—A graduat-
ing senior demonstrating promise in the
sciences from each of the New Jersey
high schools districts where Berlex oper-
ates is awarded a $2,500. The program
began in 1995.
 Sponsorship of Science Screen Report, an
award-winning video teaching tool, for
Wayne Township elementary and second-
ary schools.
 Sponsorship of the Daily Record Partners
in Education program, providing newspa-
pers in the classroom at a middle school
in Montville
 Sponsorship of school-based sports pro-
grams and “project graduations”
 Extensive support to Daytop, the New
Jersey residential and outpatient adoles-
cent substance abuse program that gives
hope to the community and restores
peace in families.
BRISTOL-MYERS SQUIBB COMPANY
Princeton
Bristol-Myers Squibb is one of the leading
diversified health and personal care companies
in the world. The company’s mission is to
develop and market innovative products that
extend and enhance human life. Bristol-Myers
Squibb has four business segments: pharma-
ceuticals, consumer medicines, nutritionals,
and medical devices. 
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New Jersey is home to two divisions of Bristol-
Myers Squibb: Worldwide Pharmaceuticals in
Princeton and ConvaTec in Skillman. 
The Bristol-Myers Squibb Science Education
Program aims to improve teaching and learn-
ing of science for all children K-8. The pro-
gram operates with the following strategic
objectives: 
 Improvement in science education prac-
tices will be accomplished through sys-
temic science education reform (SSER),
addressing local, regional and national
needs.
 All programmatic efforts must aim to
improve teaching and learning in the 
science classroom.
 Competent expert organizations will con-
tribute to SSER through coordinated
operation under alliances and partner-
ships with B-MS.
 Alliances and partnerships will be built
based on complementary expertise
among members, and effective leveraging
of resources.
 B-MS resource contribution will include
and be influenced by company employees
at all locations.
The B-MS Science Education Program archi-
tecture is based on the following five types
of strategic alliances:
 Elementary and Middle School Science
Education Reform (EMSSER) Strategic
Partnerships–Initiate and drive imple-
mentation in local public school districts
and district consortia.
 Regional NGO-Corporate-Educator
Alliances–Drive SSER dissemination at the
regional level - Leadership and
Assistance for Science Education Reform
(LASER).
 Expert Organization Alliances–Sustain
SSER through services to participating
school districts, based on subsidized fee-
for-service.
 National NGO-Corporate Alliances–
Develop and implement strategy and pro-
grams for nation-wide SSER, including
legislative lobbying.
 International NGO-Academy-Corporate
Alliances–Initiate and drive SSER in their
respective countries.
Bristol-Myers Squibb has a long history of
supporting science education through funding
and direct involvement by its scientists in the
pre-college classroom. Under its Science
Education Program, the company is taking a
strong leadership initiative to actively
strengthen science education in elementary
and middle school classrooms regionally and
nationally as well as internationally. The goal
of this coordinated reform effort is to replace
the traditional textbook instruction with
inquiry-centered, hands-on teaching and
learning of science, in which students prac-
tice problem solving, analysis and critical
thinking by systematic exploration of 
scientific concepts.
The Elementary and Middle School Science
Education Reform concept, developed by the
National Science Resources Center (NSRC) is
anchored in the National Science Education
Standards, developed by the National
Research Council under the National Academy
of Sciences. This systemic science education
reform rests on five critical elements: 1.
Curriculum; 2. Teacher professional develop-
ment; 3. Materials support; 4. Assessment;
and 5. Community partnership.
Bristol-Myers Squibb supports regional ele-
mentary and middle school science education
reform through active partnerships between
the company and individual school districts
or district consortia in all locations of the
company’s operation. Reform progress is
clearly related to shared accountability
between the company and the school district
in each of the five critical elements. 
As part of the partnership commitment,
Bristol-Myers Squibb ensures financial securi-
ty during the five-year implementation
process, and enables the districts to acquire
systems of research-based, extensively field-
tested curriculum materials designed to foster
strong inquiry behavior through guided explo-
ration, in both teachers and students. Five-
year grants range from $100,000- $500,000.
Bristol-Myers Squibb also helps develop and
support materials resource centers for kit
replenishment and distribution to all partner-
ship schools throughout the implementation
phase. The company provides venue and host-
ing for educator professional development,
local and regional conferences to build aware-
ness of, and strategic planning for systemic
science education reform. Bristol-Myers
Squibb also lends expertise in organizational
change management throughout the process.
Most importantly, B-MS assigns at least one
scientist or engineer to each partnership
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school district as part of the B-MS commit-
ment to the reform initiative. The roles of
these individuals are two-fold. 
First, the Community Scientist’s professional
training as a scientist or engineer offers the
educators-partners direct access to an
“Inquiry Role Model,“ skilled in the practice
of experimentation, data analysis, and prob-
lem solving. These skills are first and fore-
most going to be made available to the mem-
bers of the District Strategic Planning Team.
Over time, and using the expanded network
of Community Scientists in the B-MS Science
Education program, these skills will also be
available to other educators in the district.
Second, the Community Scientist will func-
tion as the liaison between the district edu-
cators and the private sector and academic
communities in the region. He/she will be
the contact person between the school dis-
trict and the B-MS Foundation, as well as
between the school district and other B-MS
Partnership districts, through the network of
B-MS Community Scientists.
The partnership school districts ensure that
conceptual and technical teacher in-service
training is offered to all teachers, and that
special efforts are dedicated to develop
strong lead teachers. The educators are
responsible for choice of curriculum materi-
als, assessment of materials, and evaluation
of teaching effectiveness. Finally, the educa-
tors are responsible for propagating reform
within the district through exemplary teach-
ing techniques. Under this reform, the
emphasis is placed on teacher empowerment,
visibility and support. 
Together the partners share the responsibility
for mentoring of new reform school districts
and new reform partners in the corporate sec-
tor, regionally, and throughout the nation.
Regional reform leaders from the ranks of
school district teachers and administrators, as
well as scientists and executives from Bristol-
Myers Squibb serve a faculty at national
Strategic Planning Institutes under the NSRC
LASER (Leadership and Assistance for Science
Educational Reform) initiative.
Bristol-Myers Squibb has initiated active
reform partnerships with twenty-three US
public school districts and education consor-
tia in four states, fourteen of which reside in
New Jersey. 
Future emphasis will be placed on the accel-
eration of Elementary and Middle School
Science Education Reform in New Jersey, east-
ern Pennsylvania and Connecticut. As of
1998, Bristol-Myers Squibb has assumed fiscal
responsibility for regional leadership team
training within a Tri-State Partnership
(including the local Building Bridges to the
Future Consortium, the Connecticut Statewide
Systemic Initiative, E. I. DuPont, Inc., the
Franklin Institute, the New Jersey Statewide
Systemic Initiative and the Merck Institute
for Science Education) in close collaboration
with the NSRC. It is estimated that, as a
direct result of this initiative, annually, no
less than fifteen new regional school districts,
or district consortia will initiate Science
Educational Reform. 
In 2001, the company launched a science
education program element to encourage all
of its employees to take active part in their
children’s science education, at home and in
the classroom. Through BLAST (Building
Leadership and Assistance for Science
Teaching) all employees can access books,
videotapes, CD’s and hands-on science kits at
science education resource centers, operating
as lending libraries. Short courses and expert
seminars are offered through video broadcast
to all sites.
PARTNERSHIPS:  Elementary and Middle
School Science Education Reform
Teacher Professional Development
Rider University RIDER SELECT Program 
for Integrated Science Teaching,
Lawrenceville, NJ
Materials Resource Center
Invention Factory Science Center, Science-to-
Go, Trenton, NJ
NSRC Strategic 
New Jersey School Districts Planning Institute
Cranbury Public Schools 1998
Ewing Township Public Schools 1995
Hillside Public Schools 2001
Hopewell Valley Regional Schools 1998
Independent Schools Leadership 
Alliance* 2001
Lawrence Township Public Schools 1995
Montgomery Township Public Schools 1996
Newark Public Schools 1998
New Brunswick Public Schools 1999
North Brunswick Public Schools 2000
Princeton Public Schools 1998
Trenton Public Schools 1996
Washington Township Public Schools 1998
West Windsor Plainsboro Regional 
Schools 1994
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C.R. BARD, INC. 
Murray Hill 
C. R. Bard, Inc. is a worldwide leader in devel-
oping, manufacturing, and supplying health-
care products that focus on vascular, urology,
and oncology disease states. In addition, Bard
offers a complete line of advanced surgical
specialty products and services that address
needs in hernia repair, performance irrigation,
hemostasis, and other areas.
Bard pioneered the development of single-
patient-use medical products for hospital 
procedures; today Bard is dedicated to pursu-
ing technological innovations that offer superi-
or clinical benefits while helping to reduce
overall costs.
Bard’s outreach programs in New Jersey
include:
 The company currently is paying off a
$100,000 pledge for capital support for
Centenary College ($20,000 per year) and
$50,000 pledge for scholarship support
($10,000 per year).
 The company currently is paying off  a
$60,000 pledge to the “Give a Boy a
Year” Financial Aid Program ($15,000 per
year) at the Delbarton School.
 Annual contribution of $5,000 to
Fairleigh Dickinson University Charter
Day Scholarship Fund.
 Annual contribution of $12,500 to the
Independent College Fund of New Jersey
in support of the C. R. Bard Foundation
Nursing Scholarship Program.
 $750 annual contribution to Junior
Achievement of New Jersey
 The company currently is paying off a
$50,000 pledge to the New Jersey SEEDS
capital campaign ($10,000 per year).
 Annual contribution of $15,000 to the
Summit Speech School early intervention
and preschool program.
 United Negro College Fund—$5,000 to
support their programs.
EISAI, INC.
Teaneck
Eisai Inc. is a wholly owned subsidiary of 
Eisai Co., Ltd. of Japan. Eisai is a human
health care corporation striving for innovative 
solutions. 
Headquartered in Teaneck, Eisai Inc.’s major
product is Aricept®, which improves cognitive
function and provides symptomatic relief for
patients suffering from mild to moderate
Alzheimer’s disease. Eisai Co., Ltd. also pro-
duces consumer health care products (non-pre-
scription pharmaceuticals); veterinary and live-
stock feed products; chemicals and food addi-
tives, and pharmaceuticals production systems
and equipment.
Eisai is currently engaged in a number of ini-
tiatives to introduce high school and college
students to the pharmaceutical industry and
other health care issues.  These include:
 Eisai worked with the United Way of
Bergen County, BD and a team of public
and private Bergen County organizations
to build awareness for NJ FamilyCare, a
publicly funded statewide health insur-
ance program.  The company invited high
school students in Bergen County to pro-
duce three-minute videos and public
service announcements to build aware-
ness for the program. The students were
provided with grants for equipment and
production costs.
 In 2001, Eisai became a corporate spon-
sor of the Rutgers MBA Program in
Pharmaceutical Management. Activities as
part of this program include:
1)  Hosted an on-site visit in March 
2002 for first year MBA students to 
meet Eisai’s business leaders and 
learn more about Eisai, as well as 
the pharmaceutical industry.  
Presentation topics included “Human
Health Care and the Economics of 
Healthcare Delivery—How the Payor 
Dynamics Impacts RX Utilization.”
2)  MBA Career Fair at Rutgers.
3)  Participating in various committees 
(i.e. Scholarship Selection, Planning 
Advisory Board).
4)  Executive Presentations at Rutgers 
MBA Courses (Including a presenta-
tion regarding product manage-
ment/marketing of branded ethical 
prescription drugs to a Rutgers MBA 
Marketing Class).
 Eisai’s Medical Services group participates
in the Doctor of Pharmacy program final
year pharmacy rotations for students at
Rutgers College of Pharmacy and for the
University of the Sciences in Philadelphia
College of Pharmacy.  The pharmacy
clerkship is a hands-on learning experi-
ence for students required for graduation.
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It allows them to gain an understanding
of the different practice environments
and responsibilities of pharmacists and
may include sites such as hospitals, 
clinics, community pharmacies, 
managed care organizations, and the
pharmaceutical industry.
JOHNSON & JOHNSON
New Brunswick
J&J is the world’s most comprehensive and
broadly-based manufacturer of health care
products, as well as a provider of related serv-
ices, for the consumer, pharmaceutical and
professional markets.                         
J&J scientists currently are engaged in
research to bring new hope to Alzheimer’s
patients, to develop treatments for ulcerative
colitis, and to find better ways to detect and
treat cancer and diabetes. Johnson &
Johnson’s prescription pharmaceuticals include
products for family planning, psychiatry,  men-
tal illness and diseases of the nervous system,
gastroenterology, oncology, immunotherapy
and cardiovascular disease, as well as biotech-
nology-derived products. The Company has
introduced prescription antifungals,
anthelmintics, antihistamines, antiparasitics
and antiallergy products.                              
Headquartered in New Brunswick, New Jersey,
since its founding in 1886, Johnson & Johnson
is recognized for its support of the communi-
ties in which the company has operations. Its
extensive social responsibility program is an
outgrowth of the Company’s renowned Credo,
which outlines its responsibilities to consumers,
employees, the community and shareowners. 
Johnson & Johnson is engaged in a number of
workforce development and education initia-
tives, including:
 Bridge to Employment is a national
school-to-career grant program active in
eight communities around the U.S. and
Puerto Rico. In NJ, the company has cur-
rent sites in Bound Brook and Trenton.
For 2002-03, J&J is developing a project
in New Brunswick with the Health Science
Technology High School.  Total grant dol-
lars for 2002-2003 New Jersey sites total
$100,000.
 Liberty Science Center (LSC) funding is
directed to the LSC’s “Cardiac Classroom,”
as well as a new effort to offer profes-
sional development for science teachers.
Cardiac Classroom exposed K-12 students
to a live, interactive, surgical procedure
with special emphasis on health care
careers.  The professional development
initiative will be an innovative experience
for teachers using the museum as a learn-
ing and teaching laboratory.  Total grant
dollars for 2002-2003 for these initiatives
total $300,000.
 J&J works with Rutgers University to fund
two major initiatives targeted to K-12
students:  the Saturday Science Academy
and the Douglass Science Institute.
These projects total approximately
$40,000.
 Independent College Fund of New
Jersey—2003 Pre-collegiate Education
Initiatives Grants as follows:  Centenary
College, $10,000 for a program to
encourage secondary students to consider
science as a career; Fairleigh Dickinson
University, $10,000 for a Pre-collegiate
Nursing Academy; Felician College,
$10,000 for an initiative to strengthen
science education for elementary and
middle school students through in-service
training for their leaders; Princeton
University, $10,000 to support the math-
ematics component of the Princeton
University Preparatory Program (PUPP);
Rider University, $10,000 for the Rider
Science Education and Literacy Center
(SELECT) Summer Research Fellows
($50,000 total).
 FIRST Robotics—J&J’s support of this
program is primarily directed to the Mid-
Atlantic robotics competition held annu-
ally at Rutgers.  FIRST was founded to
encourage interest in engineering and
technology among teenage students.  In
2002-2003, the grant totaled $375,000.
 Business Coalition for Education
Excellence.  The BCEE was founded to
advocate for high standards and assess-
ments in New Jersey public education.
J&J supports the efforts to create rigor-
ous core content standards and work-
place readiness skills.  Support for this
program is $25,000.
In addition, J&J supports the following edu-
cation organizations on an annual basis:
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InroadsNJ:  $10,000
Junior Achievement NJ: $ 5,000
NJ BISEC: $ 5,000
Public Education Institute: $10,000
Teach for America NJ: $15,000
MERCK AND COMPANY, INC.
Whitehouse Station
Merck is a global, research-driven pharmaceuti-
cal company that discovers, develops, manu-
factures and markets a broad range of human
and animal health products, directly and
through its joint ventures. 
The Merck Institute for Science Education
(MISE) is a non-profit organization estab-
lished by Merck’s Board of Directors in 1993.
The Merck Board of Directors established the
Institute with a $20 million, 10-year commit-
ment of funding from The Merck Company
Foundation.  MISE is designed to deepen cur-
rent and future teachers’ knowledge of sci-
ence and education, provide access to exem-
plary curriculum materials, and support poli-
cies at the local, state, and national levels
that promote science education—with the
ultimate goal of raising the levels of partici-
pation and performance in science for all stu-
dents in kindergarten through 8th grade.  
MISE has developed partnerships with four
public school districts located in close prox-
imity to Merck’s major facilities.  These dis-
tricts include Linden, Rahway, and
Readington Township in New Jersey, and
North Penn in Pennsylvania.  In the future,
MISE plans to expand into other school 
districts.   
In addition to creating strong school-busi-
ness partnerships with four public school dis-
tricts, MISE also has developed and imple-
mented professional development programs
and assessment tools, organized and coordi-
nated school-based volunteer activities of
300 Merck employees, provided school staff
and volunteers with access to learning mate-
rials through two resource centers, and
played a lead role in developing New Jersey’s
core curriculum content standards and frame-
works for science.  Since its inception, MISE’s
capacity has been significantly strengthened
through the receipt of a five-year, $2.4 
million grant from the National Science
Foundation (NSF) and the creation of an
Advisory Board comprised of national experts
in the sciences and education.  
MISE and its district partners have estab-
lished model professional development pro-
grams (the Leader Teacher Institute and the
Peer Teacher Workshops) for elementary and
middle school teachers and administrators.
Through these programs, approximately 1,500
participants have attended intensive, hands-
on workshops and received ongoing technical
assistance in science, mathematics, and tech-
nology. As a result of participating in such
training, these educators have the potential
to impact nearly 20,000 students within
Merck’s neighboring communities.
 The Leader Teacher Institute (1995-98)
was a three-year professional develop-
ment program for K-8 teachers in the
partner districts.  This program was
designed to increase participants’ con-
tent knowledge in science, mathematics,
and technology, to model inquiry-cen-
tered instruction, and to build the capac-
ity of teachers to lead education reform
in their districts.
 The Peer Teacher Workshops, which have
been offered since 1996 in the partner
districts, provide intense, focused oppor-
tunities for all teachers in the partner-
ship districts to study and apply stan-
dards-based science and mathematics
concepts and the supporting technology,
inquiry-centered instructional strategies,
equitable classroom practices, and 
assessment.  
MISE has organized and coordinated the
activities of approximately 300 employees
from two Merck sites who volunteer their time
in the partner district schools.  Among the
activities the volunteers engage in are Family
Science Day, science fairs, classroom partner-
ships, and a new “telementoring” program.
Assessment Tools: With the support of an NSF
grant, MISE embarked on a Partnership
Assessment Project to develop accurate meas-
ures for testing student understanding in sci-
ence.  This project resulted in the publication
of “An Assessment Sampler”—a classroom
resource for teachers, administrators, and
staff developers.  MISE and its partners have
also developed a four-component Partnership
Assessment Plan, which has begun to address
the districts’ assessment needs in science.  
Resource Centers: Two resource centers—one
in Rahway, New Jersey, and one in West
Point, Pennsylvania—have been developed
and staffed by MISE. Through these centers,
local teachers, administrators, school board
members, and Merck employee volunteers may
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access a variety of instructional materials,
books, periodicals, and videotapes focused on
effective science and mathematics teaching.  
Core Curriculum Content Standards: MISE
executive director, Dr. Carlo Parravano, was
appointed co-chair of New Jersey’s first
Professional Teaching Standards Board and
helped develop statewide science standards
and frameworks, forming the basis for science
education in New Jersey.
NOVARTIS PHARMACEUTICALS
East Hanover
Novartis Pharmaceuticals, a division of
Novartis, is a leading pharmaceutical company
formed in December 1996 by the merger of
Ciba-Geigy Ltd. and Sandoz Ltd. The company
researches, develops, manufactures and mar-
kets leading innovative prescription drugs.  
The company’s U.S. headquarters are in East
Hanover, New Jersey, with a research facility in
Summit. Novartis Pharmaceuticals employs
approximately 3,500 people in New Jersey. The
pharmaceutical company focuses on seven ther-
apeutic areas: transplantation/immunology;
arthritis/inflammation/bone; cardiovascular
and metabolic; nervous system; dermatology;
oncology; and respiratory. 
Novartis provides support to a number of
organizations in New Jersey, including:
Workforce Partnerships:
 Black United Fund
 The Business and Education Together
Foundation (BET)
 CCB International
 Employment Horizons (Occupational
Training Center of Morris County)
 Summit YMCA - Black Achievers Corporate
Mentor Program
 Technical Training Project, Inc.
Elementary and High School Program Support:
 LINK Community Schools
 Chatham High School
 Florham Park PTA
 Hanover Park High School
 Holy Family School
 John F. Kennedy School
 Mount Olive High School
 Mountainside PTA
 North Hunterdon High School
 Our Lady of Peace School
 Parsippany Hills High School
 Randolph High School
 The School for Children with Hidden
Intelligence
 Whippany Park High School
 Summit High School
 The Wilson School Parent’s Association
 In addition, Novartis has a weekly men-
toring program that pairs employees 
with third and fourth graders from 
New Jersey’s inner cities. Novartis is 
in its second year of this on-site 
mentor program.
NOVO NORDISK 
PHARMACEUTICALS, INC.
Princeton
Novo Nordisk Pharmaceuticals, Inc., is a
United States affiliate of Novo Nordisk A/S,
Denmark, a multinational company that is a
world leader in diabetes care. Novo Nordisk
has a broad diabetes product portfolio, includ-
ing the most advanced products within the
area of insulin delivery systems and the richest
product pipeline in the industry. In addition,
Novo Nordisk has a leading position within
such areas such as hemostasis management,
growth disorders and hormone replacement
therapy.
Outreach programs with New Jersey educa-
tional institutions include:
 College of New Jersey:  employed student
interns and offered positions upon grad-
uation.
 Fairleigh Dickinson University:  Presented
Global Leadership Program, and worked
with the university to design training
programs.
 Mercer Community College:  Partnered on
computer training and received assis-
tance in preparing the state training
grant.
 Rutgers University:  participate in job
fairs for upcoming graduates, as well as
post jobs with the college when the
company has openings in the pharma-
ceutical area.
 Rider University:  post jobs with the 
college.
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For all of the above, the company provides
tuition reimbursement to employees based on
eligibility and policy requirements. 
ORGANON, INC.
Roseland
Organon Inc. of Roseland and West Orange, is
the U.S. affiliate of N.V. Organon, a renowned
international ethical pharmaceutical company
(its world pharmaceutical headquarters relocat-
ed to Roseland in 2002). Organon has com-
plied a long and impressive list of firsts in
pharmaceutical discovery and development,
innovative, new generation products. 
Strong reliance on its expertise in research and
development and unprecedented commitment
to women’s health care allowed Organon to
contribute significantly to three areas of vital
importance—contraception, fertility and osteo-
porosis prevention—and placed the company
in range of world leaders in this field.
Organon’s scientists and research assistants
worldwide have also added strongly to ground-
breaking research programs and treatment of
central nervous system disorders, especially
depression and psychosis as well as diversified
and highly specialized anesthesia products.
Organon has developed a number of partner-
ship opportunities with New Jersey colleges
and universities, including:
 Ongoing partnership with Montclair State
University that includes “lunch & learn”
programs (e.g. become debt free, retire-
ment planning) and supportive/develop-
ment skills courses (e.g. cultural diversi-
ty, business writing).  Organon is also
looking into the possibility of offering an
on-site evening GMAT prep course.  
 Caldwell College has participated in on-
site “lunch & learn” program on distance
learning.  Organon recently  again hosted
Caldwell College for a lunch & learn pro-
gram on opportunities available at the
college, as well as an introduction to its
Principles of Management undergraduate
course.  An evaluation is being conduct-
ed as to whether there is enough interest
at Organon to pursue offering this course
on-site to our employees after work.
 Currently, Organon is in discussion with
UMDNJ to develop opportunities for a
partnership- particularly for conducting
clinical trials.  Representatives from sev-
eral of Organon’s departments—including
Marketing, Sales, and Clinical and Medical
Services—were present during the kick-
off meeting in January and several of
these groups have also met separately
with UMDNJ.
 Plans are underway to offer Organon
employees an on-site MBA course with
Fairleigh Dickinson University for the 
Fall 2002 semester.  A number of employ-
ees are currently pursuing a Master’s
degree in Pharmaceutical/Chemical 
studies at FDU.  
 Preliminary discussions are underway
with County of Morris College to estab-
lish partnerships.
PFIZER, INC.
Morris Plains 
Pfizer is a research-based, global pharmaceuti-
cal company. Pfizer has three business seg-
ments: health care, consumer health care, and
animal health. Pfizer’s pharmaceutical product
portfolio is one of the broadest and deepest in
the industry, covering cardiovascular disease,
infectious disease, diseases of the central nerv-
ous system, metabolic disorders, cancer,
inflammatory disease, women’s health and
ophthalmology. 
In 1999, Pfizer made over $6.8 million in
charitable contributions and product dona-
tions in the state of New Jersey. In addition,
Pfizer conducts a number of educational ini-
tiatives, including:
 Pfizer provides two scholarships totalling
$20,000 annually to support two stu-
dents’ tuition in the Rutgers University
MBA in Pharmaceutical Management.
 Morristown High School Career Academy,
2002.
 Independent College Fund of New Jersey,
Unrestricted. 
 Pfizer Science Grants Contribution, 2002,
Chester Board of Education.
 2002 Chester Science Fair, and North
Hunterdon High School Science Fair.
 Science Expo 2002, 2/21/2002, County
College of Morris County Foundation
Scholarship. 
 2002, Liberty Science Center.
 Traveling Science Program, 2002, 
New Jersey Seeds.
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 Science Curriculum, 2002, North Jersey
Regional Science Fair
 Regional Science Fair, 2002,  College of
St. Elizabeth
 Scholarship, 2002, Centenary College
 Scholarship, 2002, Fairleigh Dickinson
University
 Scholarship, 2002, Fairleigh Dickinson
University
 Scholarship, 2002, Tri-County Scholarship
Fund
 Scholarship, 2002, Children on the Green
Child Care
 Tuition Slots for Homeless Children, 2002
 New Jersey City University Foundation,
Joseph DeLuca Pfizer Memorial
Scholarship Fund, 2002
 Ada Budrick Child Care & Learning Center,
Reading Enrichment for Kindergartners,
2002
 Link Community School Scholarship,
November 2002
PHARMACIA CORPORATION
Peapack
Pharmacia Corporation has a significantly
strengthened position in the critical U.S.
pharmaceutical market and complementary cur-
rent and near-term products in key therapeutic
areas. The company has strong positions in the
areas of arthritis and inflammation, antibi-
otics, oncology, cardiovascular, central nervous
system, ophthalmology, urology, and women’s
health. Pharmacia also has a strong consumer
healthcare business led by global brands such
as NICORETTE.
Pharmacia has a number of workforce and
education partnerships, including those with
the following New Jersey institutions:
 Caldwell College
 Fairleigh Dickinson University
 Gill St. Bernard’s School
 Independent College Fund of New Jersey
 New Jersey SEEDS
 New Jersey Business/Industry/Science
Education Consortium
 Newark Academy
 Raritan Valley Community College
 Rutgers University
 Science Screen Report (Bedminster and
Somerset Hill district schools)
 Somerset/Hunterdon Business and
Education Partnership
 Teach for America
ROCHE
Nutley
Roche, based in Nutley, N.J., is the U.S. pre-
scription drug unit of the Roche Group, a lead-
ing research-based health care enterprise that
ranks among the world’s leaders in pharmaceu-
ticals, diagnostics and vitamins.  Roche discov-
ers, develops, manufactures and markets
numerous important prescription drugs that
enhance people’s health, well-being and quali-
ty of life.  Among the company’s areas of ther-
apeutic interest are:  dermatology; genitouri-
nary disease; infectious diseases, including
influenza; inflammation, including arthritis
and osteoporosis; metabolic diseases, includ-
ing obesity and diabetes; neurology; oncology;
transplantation; vascular diseases; and virolo-
gy, including HIV/AIDS and hepatitis C.
Roche has a long history and commitment to
philanthropy and social responsibility and as
one of the first companies in the United
States to start a corporate giving program,
its actions today continue to demonstrate the
company’s belief in the importance of good
corporate citizenship.  Among the many ini-
tiatives Roche has supported:
 Roche conducts an annual career day at
which local elementary through high
school students are invited to attend and
learn about careers in the pharmaceuti-
cal industry through information and
hands-on activities. 
 Working with the Clifton public schools,
Roche has implemented a Full Option
Science System (FOSS), a modular sci-
ence program for K-6 students that inte-
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grates hands-on real world science with
interactive multimedia materials. 
 Roche supports the annual Dr. Virginius
D. Mattia Scholarship program for col-
lege-bound high school students from
Nutley.
 Independent College Fund of New
Jersey/September 11th Victim Assistance
Postsecondary Education Fund:  Support
through the Hoffmann-La Roche
Foundation for a special post-secondary
student assistance fund to help NJ vic-
tims with postsecondary needs as a com-
pliment to assistance from the state. 
 INROADS:  Roche provides support to
this minority intern program.  Most par-
ticipants attend New Jersey colleges and
universities. 
 Montclair State University (MSU):  Roche
funded MSU’s College of Science and
Mathematics’ development and imple-
mentation of a Focus School in Science
in the Passaic school district.  It pro-
vides new science teaching models for
elementary educators through training,
materials, and hands-on activities, as
well as a bilingual component. 
 New Jersey Science Education Leadership
Association (NJSELA) and New Choices,
New Responsibilities:  Ethical Issues in
the Life Sciences (NCNR):  Roche funded
and collaborated on development of
NCNR, a curriculum supplement in
bioethics for middle and high school sci-
ence teachers in New Jersey.  Using a
case-study method, teachers are trained
and are provided with materials for class-
room discussion on the topics of AIDS,
animals in science, genetics, transplanta-
tion and the environment. 
 Paterson Education Fund (PEF).  The
Roche Tutoring Program offers support for
partnership with Edward Kilpatrick School
in Paterson and PEF to conduct a weekly
tutoring program from September through
May for third graders at Roche in Nutley.
Library Power  offers support for pro-
grams to rebuild the public high schools’
library media programs.  Returning to
Local Control:  Access to Tools offers sup-
port for initiatives to educate community
about the role of school governance in
school reform.  Comprehensive School
Health Initiative Assessment offers sup-
port for programs designed to determine
the health needs and available resources
for children in Paterson.
 The Rutgers University Fellow’s Program,
of which Roche is a founding member,
offers two-year industry fellowships.  The
MBA in Pharmaceutical Management pro-
vides scholarships, and Roche sits on the
advisory board, as well as interviewing
and academic committees. Robert B.
Clark Scholars are awarded to minority
undergraduate students pursuing careers
in science. 
 Technical Training Project, Inc. (TTP):
Roche was a founding member and sup-
ports TTP, which offers training and
career opportunities for minorities in
preparation for careers in science and
technology. 
 University of Medicine and Dentistry of
New Jersey (UMDNJ):  The Environmental
and Occupational Health Sciences
Institute (EOHSI) and the Nutley School
District:  Roche has been a corporate
sponsor of partnerships between EOHSI
and the Nutley school district to train
educators on priority environmental
health issues to improve environmental
health sciences education for elementary
through high school students. 
 Teach for America.  Consistent with
Roche’s commitment to educational pro-
grams which enhance math and science
literacy, especially for traditionally under-
served populations, Roche has provided
support to Teach for America for the
sponsorship of corps members who teach
in Paterson’s public schools. 
 Robert B. Clarke Roche Scholarship at
Rutgers University.  Roche established a
scholarship program at Rutgers University
for undergraduate students in under-rep-
resented groups whom plan to pursue
careers in mathematics, science, pharma-
cy or nursing.  The program awards merit
scholarships based on the promise of
academic excellence and financial need.
 Nursing Scholarship Program. Roche 
supported the New Jersey Institute of
Nursing’s scholarship program for 
returning nursing students affiliated 
with New Jersey’s hospitals, colleges, 
and universities. 
Roche has also provided support to the fol-
lowing New Jersey institutions of higher 
education:
 Bloomfield College
 Caldwell College
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 Drew University
 Fairleigh Dickinson University
 Montclair State University
 New Jersey Institute of Technology
 Ramapo College
 Rutgers University
 Seton Hall University
 University of Medicine and Dentistry
 Warren County Community College
 William Paterson University
SANKYO PHARMA INC.
Parsippany
Sankyo Pharma Inc. is the U.S. subsidiary of
Tokyo-based Sankyo Co., Ltd., the second-
largest pharmaceutical company in Japan.
Sankyo is a bold innovator with a strong track
record of discovering new classes of medicine.
Sankyo researchers are focused on developing
breakthrough therapies for the treatment of
cardiovascular conditions, metabolic disor-
ders/diabetes infection, and cancer.  Sankyo
established its U.S. headquarters in New Jersey
in 2001. 
Sankyo has a fellowship arrangement with
Rutgers University.  It is a one-year post-doc-
toral Industrial Fellowship in Medical and
Scientific Affairs.  Sankyo’s first fellow recent-
ly completed her year-long fellowship (and
was hired into the company), and Sankyo
began two new fellowships on July 1, 2002.
SCHERING-PLOUGH CORPORATION
Kenilworth
Schering-Plough Corporation is a leading
research-based company involved in the discov-
ery, development, manufacturing and marketing
of pharmaceutical products worldwide.
Schering-Plough is a publicly traded company
with shared listed on the New York Stock
Exchange (ticker symbol SGP).  Some 30,000
company employees serve the health and per-
sonal care needs of people in more than 125
world markets.
In targeted geographic and therapeutic mar-
kets, Schering-Plough is achieving important
gains with new products derived from a  pro-
ductive research pipeline and external licens-
ing/co-development agreements.  The Company
seeks to address medical and customer needs,
as well as the latest trends in world health care
systems.  Pharmaceutical research and develop-
ment efforts, carried out by Schering-Plough
Research Institute, are concentrated in:  aller-
gic and inflammatory disorders; infectious dis-
eases; oncology; cardiovascular disease; and
central nervous system disorders.
Schering-Plough is actively engaged in a vari-
ety of workforce development and education
projects in New Jersey, including:                  
 An internship program for high school
students, with twelve to eighteen partici-
pants selected per year.  In this program,
high school students are offered a stipend
for their work as interns.
 An internship program for college stu-
dents that enrolls approximately 100
interns from NJ schools annually, with 
a stipend.
 Scholarships earmarked for training in
the pharmaceutical industry are also 
provided.
 An annual summer program for middle
school science teachers, the
 Schering-Plough Summer Institute for
Teachers Program. Participants receive a
$2500 stipend. 
 Provided financial support to the NJ
Business and Industry Association’s
Science Education Consortium (NJBISEC).
This typically involves middle school
teachers in Sussex County.  They work
during the summer months in S-P’s
Lafayette, NJ facility.                            
 Annual program whereby biology/science
middle school faculty work in the
Schering-Plough Research Institute labs
for four weeks during the summer period,
to hone research skills and stay current.
In addition, a College Alliance Program
supported by Development Operations
(part of the Research Institute) provides
two professors from local colleges with
operations research work as part of their
annual college/university sabbatical.  
 Schering-Plough has made a number of
equipment donations to local educational
institutions, including 2000 laptops to
NJ K-12 school nurses; renovated facili-
ties and donated equipment at Union
High School (an approximate value of
$250,000).  In addition, the company
donated used lab equipment to local col-
leges (Stevens, Seton Hall, and Rutgers).   
 Schering-Plough has assisted local sec-
ondary institutions with curriculum
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development (Union and Kenilworth High
Schools), as well as renovated laborato-
ries and provided guidance on a science
programs, at an investment of $350,000.
The company has several high school
students from advanced placement pro-
grams visit Schering-Plough for two to
three days each during the school year, 
augmenting their high school 
science program. 
 During 2001, Schering-Plough provided
technical guidance to NJIT regarding the
development of curriculum addressing
operations research.
 Communities in Schools (CIS) of New
Jersey, Inc., Newark-Supported CIS of
Elizabeth High School/Sunset Program
for potential high school dropouts. 
 Schering-Plough has provided staff to
serve as classroom instructors to local
schools, providing scientists within
Union County as classroom assistants
(middle school and high school) and 2-3
assistants at summer camps for elemen-
tary students.  In addition, the company
annually provides upwards of 60 scien-
tists and professionals guest lecturers to
present at elementary, middle schools,
high school and college institutions.
 Schering-Plough has sponsored Career
Awareness Days, including the Women in
Science and Technology Day, at Kean
University Career Day; In addition, there
is a special program for 9th grade girls
to visit Schering-Plough annually.
Schering-Plough also sponsors several
annual tours of the Research Institute
involving approximately 300 NJ students.
 Provided annual financial support
($10,000-$30,000) to the Northern New
Jersey INROADS Program for exemplary
African-American and Hispanic New
Jersey college students (from Rutgers
University, Seton Hall, New Jersey
Institute of Technology, Stevens
Institute, Kean University, and Fairleigh
Dickinson).  Upwards of ten college stu-
dents receive paid summer internships
and consideration for full time employ-
ment following graduation.
 Provided annual financial grant of
$20,000 to Technical Training Project,
Inc., (TT), promoting the preparation and
training of recent inner city minority New
Jersey high school graduates for careers
in science.  TTP is a private non-profit
organization associated with Essex
County College.  Since 1968, Schering-
Plough has had approximately 300
African-American and Hispanic students
training and approximately 50 have been
hired as lab technicians in Schering-
Plough Research Institute and Technical
Operations. 
 Created the Summer Challenge Program
involving upwards of 25 minority college
students for summer assignments princi-
pally from New Jersey-based colleges and
universities.
 Schering-Plough has a program in which
upwards of $1,000 total in savings bonds
is given to as many as 30 K-12 local 
students who excel within their school’s
science programs.
 Finally, Schering-Plough has made signifi-
cant monetary contributions to New
Jersey education institutions and initia-
tives, including $646,000 in 2001 to NJ
colleges and universities. As part of the
amount above, the Schering-Plough
Foundation Scholars Program awards
scholarships to high school and college
students with special financial needs who
display exceptional academic abilities,
leadership, and a commitment to commu-
nity service. Institutions include:
Bloomfield College; Delbarton School;
Drew University; Fairleigh Dickinson
University; Kean University; Kent Place
School; Montclair State University;
Newark Academy; Pingry School; 
Rutgers, New Brunswick; Seton Hall
Preparatory; and, St. Benedict’s
Preparatory School.
In addition to the above, funded the 
following initiatives: 
 Drew University- Awarded grant for the 
renovation of the “Schering-Plough Hall 
of Sciences Lecture Hall.”
 Kean University-Funded the newly created
graduate program in biotechnology.
 Link Community School, Newark- Funded 
a new science program.
 Union County College- Funded construc-
tion of the “Schering-Plough Training 
Institute” at the Elizabeth campus.
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STRYKER HOWMEDICA OSTEONICS
Allendale
Stryker Howmedica Osteonics is headquartered
in Allendale, New Jersey.  Howmedica
Osteonics Corp. is a leading worldwide manu-
facturer and developer of orthopaedic products
that include hip and knee reconstructive
devices, upper extremity implants, bone
cement, and trauma products. Howmedica
Osteonics also represents the spinal implants
manufactured by Stryker Spine. 
Howmedica Osteonics is dedicated to establish-
ing itself as the undisputed leader in
orthopaedics through building intense customer
loyalty, which makes it the company of choice
for worldwide customers, business partners,
and employees alike.  
Stryker has an impressive inventory of  NJ
Workforce Partnerships & Assistance Programs
for Elementary and high school districts in
the state, including:
 Partnership with Bergen Community
College, regarding the creation of a
Manufacturing Technology Education
Center.  Create and support manufactur-
ing technology simulation laboratory, CAD
classrooms, provide assistance with cur-
riculum creation, part-time adjunct
instructors, co-operative students and/or
work/study arrangements. Stryker has
committed to donate $100,000 toward
this center. Passaic County Community
College also is a part of this program.
 Co-operative education opportunities for
college students from NJIT, Ramapo
College, Rutgers, Stevens Institute of
Technology, and Montclair University in
engineering disciplines, IT, Finance and
Marketing.  There are graduate recruiting
programs on these campus.
 Supporting numerous career fairs at local
schools.
 “Bring Your Daughters to Work” Day,
“Bring Your Sons to Work” Day involve
school aged children 9-15 exposure to
medical device manufacturing & 
technology.
 Support of Northern Highlands Regional
High School and Mahwah High School
DECA program.
 Partnership with Ramapo College regard-
ing guest lecturing on intellectual prop-
erty, human resources and information
technology areas.  Faculty tours on-site.
 Over past seven years, counseled the
Workforce Investment Board of Bergen
County on “School to Work” programs 
and policy.
WYETH
Madison
Wyeth (formerly American Home Products) is
one of the world’s largest research-based
pharmaceutical and health care products com-
panies. It is a leader in the discovery, develop-
ment, manufacturing and marketing of pre-
scription drugs and over-the-counter medica-
tions. It is also a global leader in vaccines,
biotechnology, and animal health care. Wyeth
is among the leaders in sales of non-prescrip-
tion medications worldwide and the leader in
vitamin sales in the United States. 
Wyeth is currently engaged in a number of
education and workforce programs in New
Jersey, including:
 Executive Scholars Program at Fairleigh
Dickinson University (FDU), which
includes Human Resources Executives
serving as mentors for students, and
hosting “interviewing skills” workshop for
FDU students and mentors in program
 Partnership with Rutgers University that
includes intern recruitment efforts and
programs with the Rutgers School of
Pharmacy
 The In Roads Program, in which Wyeth
works with InRoads to seek out interns
at local universities to expand diversity
within the company.
 Wyeth also contributes financially to a
number of educational programs in NJ,
including Drew University, Seton Hall
University, and the Liberty Science
Center.
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